Shares of XPH Now Oversold
October 26, 2017 at 16:09 PM EDT
In trading on Thursday, shares of the SPDR S&P Pharmaceuticals ETF (XPH) entered into oversold territory, changing hands as low as $41.02 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on a scale of zero to 100..